Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - LifeCore Biomedical, Inc. (NasdaqNM:LCBM)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Options
Recent Events
Aug 14Earnings Announcement
Location
3515 Lyman Boulevard
Chaska, MN 55318
Phone: (952) 368-4300
Fax: (952) 368-3411
Email: info@lifecore.com
Employees (last reported count): 170
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 41%
·Over the last 6 months:
 · one insider sell; 5,000  shares
·Institutional: 34% (57% of float)
(39 institutions)
·Net Inst. Selling: 3,000  shares
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
LifeCore Biomedical, Inc. develops, manufactures, and markets biomaterials and surgical devices through two divisions: the Hyaluronan Division and the Oral Restorative Division. The Hyaluronan Division principally is involved in the development and manufacture of products utilizing hyaluronan, a naturally occurring carbohydrate that moisturizes or lubricates the soft tissues of the body. The Hyaluronan Division's primary development project involves a version of Lifecore's patented ferric hyaluronan technology, GYNECARE INTERGEL Adhesion Prevention Solution, which is a second-generation product with potential application in reducing the incidence of post-surgical adhesions. The Oral Restorative Division markets a comprehensive line of titanium-based dental implants for replacement of lost or extracted teeth.
More from Market Guide: Expanded Business Description

Financial Summary
Lifecore Biomedical, Inc. develops, manufactures and markets surgical devices through two divisions, the Hyaluronate Division and the Oral Restorative Division. For the nine months ended 3/31/01, net sales increased 6% to $25.2 million. Net loss rose from $425 thousand to $1.8 million. Revenues reflect higher ophthalmic and orthopedic bone-regeneration hyaluronan sales. Higher losses reflect unabsorbed excess capacity costs and expenses from Lifecore Germany.

Recent Earnings Announcement
For the 3 months ended 06/30/2001, revenues were 8,896; after tax earnings were -1,913. (Preliminary; reported in thousands of dollars.)

More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

John Bracke, Ph.D., 53
Pres, CEO, Sec., Director
$319K$42K
Dennis Allingham, 53
Exec. VP, CFO
203K--  
Colleen Olson, 53
VP of Corp. Admin. Operations
146K--  
Brian Kane, 53
VP of New Bus. Devleopment and Marketing
163K--  
Dollar amounts are as of 30-June-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:LCBMAs of 31-Aug-2001
Price and Volume
52-Week Low
on 21-Dec-2000
$3.375
Recent Price$6.35 
52-Week High
on 1-Sep-2000
$8.50 
Beta1.24 
Daily Volume (3-month avg)17.8K
Daily Volume (10-day avg)43.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change-25.3%
52-Week Change
relative to S&P500
+0.2%
Share-Related Items
Market Capitalization$80.4M
Shares Outstanding12.7M
Float7.50M
Dividends & Splits
Annual Dividendnone 
Last Split: 3 for 1 on 21-Nov-1983
Per-Share Data
Book Value (mrq*)$4.25 
Earnings (ttm)-$0.29 
Earnings (mrq)-$0.15 
Sales (ttm)$2.70 
Cash (mrq*)$0.18 
Valuation Ratios
Price/Book (mrq*)1.50 
Price/EarningsN/A 
Price/Sales (ttm)2.35 
Income Statements
Sales (ttm)$34.1M
EBITDA (ttm*)-$2.15M
Income available to common (ttm)-$3.70M
Profitability
Profit Margin (ttm)-10.8%
Operating Margin (ttm)-6.5%
Fiscal Year
Fiscal Year EndsJune 30
Most recent quarter
(fully updated)
31-Mar-2001
Most recent quarter
(flash earnings)
30-June-2001
Management Effectiveness
Return on Assets (ttm)-5.77%
Return on Equity (ttm)-6.78%
Financial Strength
Current Ratio (mrq*)6.37 
Debt/Equity (mrq*)0.12 
Total Cash (mrq)$2.31M
Short Interest
As of 8-Aug-2001
Shares Short27.0K
Percent of Float0.4%
Shares Short
(Prior Month)
26.0K
Short Ratio1.93 
Daily Volume14.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001, except mrq*/ttm* items as of 31-Mar-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Event data provided by CCBN. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.